Scholar Rock (NASDAQ:SRRK) Stock Rating Upgraded by Wall Street Zen

Scholar Rock logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded Scholar Rock from “sell” to “hold.” Across analysts, the stock has a “Moderate Buy” consensus rating and an average price target of $69.50.
  • Scholar Rock reported a quarterly loss of $0.81 per share, narrower than the $0.85 loss analysts expected; revenue of $570,000 also exceeded the $300,000 consensus estimate.
  • Director Srinivas Akkaraju bought 146,970 shares for about $6.1 million. The stock was reported down 4.4% and opened at $48.13 on Friday.
  • MarketBeat previews top five stocks to own in December.

Scholar Rock (NASDAQ:SRRK - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "sell" rating to a "hold" rating in a report issued on Saturday, Wall Street Zen reports.

SRRK has been the subject of several other reports. HC Wainwright boosted their target price on shares of Scholar Rock from $65.00 to $70.00 and gave the company a "buy" rating in a research report on Tuesday, September 15th. BMO Capital Markets upped their target price on shares of Scholar Rock from $76.00 to $84.00 and gave the company an "outperform" rating in a report on Monday, September 14th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $70.00 target price on shares of Scholar Rock in a report on Monday, September 21st. Citigroup increased their price target on shares of Scholar Rock from $60.00 to $74.00 and gave the stock a "buy" rating in a research report on Monday, September 14th. Finally, Evercore reiterated an "outperform" rating and set a $72.00 price target on shares of Scholar Rock in a research note on Tuesday, September 15th. Three investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $69.50.

Read Our Latest Stock Analysis on Scholar Rock

Scholar Rock Trading Down 4.4%

Scholar Rock stock opened at $48.13 on Friday. The business has a 50-day simple moving average of $45.28 and a two-hundred day simple moving average of $48.26. The company has a market cap of $5.87 billion, a P/E ratio of -14.32 and a beta of 0.78. Scholar Rock has a 52-week low of $38.02 and a 52-week high of $61.76. The company has a quick ratio of 5.40, a current ratio of 5.41 and a debt-to-equity ratio of 1.16.

Scholar Rock (NASDAQ:SRRK - Get Free Report) last released its quarterly earnings results on Tuesday, November 10th. The company reported ($0.81) EPS for the quarter, beating the consensus estimate of ($0.85) by $0.04. The business had revenue of $0.57 million for the quarter, compared to analysts' expectations of $0.30 million. During the same period in the previous year, the company earned ($0.90) EPS. Analysts predict that Scholar Rock will post -3.04 EPS for the current year.

Insider Buying and Selling

In related news, Director Srinivas Akkaraju purchased 146,970 shares of Scholar Rock stock in a transaction on Monday, October 26th. The stock was acquired at an average price of $41.59 per share, for a total transaction of $6,112,482.30. Following the completion of the transaction, the director directly owned 6,380,517 shares in the company, valued at $265,365,702.03. This represents a 2.36% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 10.30% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. American Century Companies Inc. boosted its stake in Scholar Rock by 5.9% in the 3rd quarter. American Century Companies Inc. now owns 1,033,050 shares of the company's stock worth $49,917,000 after purchasing an additional 57,853 shares during the period. Allworth Financial LP grew its holdings in Scholar Rock by 171.4% during the 3rd quarter. Allworth Financial LP now owns 1,715 shares of the company's stock valued at $83,000 after buying an additional 1,083 shares in the last quarter. Aquatic Capital Management LLC bought a new stake in shares of Scholar Rock during the third quarter valued at approximately $1,450,000. Goldman Sachs Group Inc. raised its position in shares of Scholar Rock by 39.0% during the third quarter. Goldman Sachs Group Inc. now owns 1,961,931 shares of the company's stock valued at $94,801,000 after buying an additional 550,454 shares during the last quarter. Finally, Bellevue Group AG lifted its holdings in shares of Scholar Rock by 13.8% in the third quarter. Bellevue Group AG now owns 2,786,925 shares of the company's stock worth $134,664,000 after buying an additional 337,378 shares in the last quarter. 91.08% of the stock is owned by hedge funds and other institutional investors.

About Scholar Rock

(Get Free Report)

Scholar Rock is a biopharmaceutical company based in Cambridge, Massachusetts, that develops medicines targeting growth factors and signaling proteins involved in disease. Its research has focused on the transforming growth factor beta (TGF-β) superfamily, which plays roles in processes including muscle development and immune regulation. The company's lead program has been apitegromab, a selective inhibitor of myostatin developed for spinal muscular atrophy (SMA). Scholar Rock has studied the medicine as a potential treatment alongside existing SMA therapies, with the goal of improving patients' motor function.

Further Reading

Analyst Recommendations for Scholar Rock (NASDAQ:SRRK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Scholar Rock Right Now?

Before you consider Scholar Rock, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scholar Rock wasn't on the list.

While Scholar Rock currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines